September is Ovarian Cancer Awareness Month. Committed to raising awareness about the disease, the Susan F. Smith Center for Women's Cancers at Dana-Farber collaborated with the M. Patricia Cronin Foundation to Fight Ovarian Cancer, and the Massachusetts Department of Public Health to create the Massachusetts OvarianCancerAwareness.org Coalition. Together, we have one common goal: increasing awareness of ovarian cancer.
Dr. Ursula Matulonis, Medical Director of GYN Oncology at the Susan F. Smith Center for Women's Cancers, was featured with her patient, Beverly, during the fourth Biennial Stand Up 2 Cancer telecast, which aired on all major television networks on Friday night, September 5.
View the CBS Health Watch PSA: Get the facts about ovarian cancer
Tuesday, Sept. 16, 12:00 p.m.
Join us for a live video webchat panel with Ursula Matulonis, MD, medical director of the Gynecologic Oncology Program, and gynecologic oncologists Panos Konstantinopoulos, MD, PhD, and Susana Campos, MD, MPH.
It's been suggested that regular use of talcum powder products in the genital area might increase the possibility of ovarian cancer. Research on this potential link has yielded mixed findings, with some studies finding a small increase in risk.
Dana-Farber Cancer Institute recently partnered with CancerConnect and Ursula Matulonis, MD, to answer questions about ovarian cancer. Experts in the Susan F. Smith Center for Women's Cancers offer the latest research and treatment for this type of cancer.
After a long period of slow progress, new knowledge about the genetics of ovarian cancer is leading to the development and testing of new therapies.
"I can't pinpoint when I started to get ovarian cancer symptoms. It was all very subtle and gradual. I was a healthy person. I ran, biked swam, hiked, and went to the gym regularly..."
A diagnosis of ovarian cancer can raise a lot of questions. It can also raise many new medical terms, which your doctor or a member of your care team can explain. Here are a few terms to know.
"After being diagnosed with advanced (stage 3C) ovarian cancer in 2008, I chose Dana-Farber for my care because I knew about the Institute's cutting-edge approach to cancer care and research..."
It's estimated that more than 22,000 new cases of ovarian cancer will be found in 2012. In many cases of this disease, the cancer is not detected until it's advanced. It's important to recognize the symptoms and take early action.
Pass it on. Save a life. Learn more about the disease, symptoms, and risk factors in this short presentation. Help increase awareness about this disease and share it with the women in your life.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: